Developing New Treatments for Severe Preeclampsia

开发治疗严重先兆子痫的新疗法

• 批准号: nhmrc : GNT1160684
• 负责人: Dr Sarah Marshall
• 金额: $ 32.72万
• 依托单位: Monash University
• 依托单位国家: 澳大利亚
• 项目类别: Early Career Fellowships
• 财政年份: 2019
• 资助国家: 澳大利亚
• 起止时间: 2019-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/developing-new-treatments-severe-preeclampsia/1349320
• 关键词: Developing; New; Treatments; Severe; Preeclampsia

In 20% of pregnancies women have to have their baby very early because the woman herself becomes extremely sick due to a condition called preeclampsia. Our current treatments for preeclampsia don’t work sufficiently well in everyone. Through my research, I aim to develop new and better treatments that will allow women with even the worst preeclampsia to continue their pregnancy so that their baby can be born better grown and more healthy.

20% 的怀孕女性必须很早就生孩子，因为女性本身会因先兆子痫而病情严重。我们目前的先兆子痫治疗方法并不能对每个人都有效。通过我的研究，我的目标是开发新的、更好的治疗方法，让患有最严重先兆子痫的女性能够继续怀孕，以便她们的孩子出生时能够更好地成长和更健康。